Stay updated on Efruxifermin in NASH Subjects Clinical Trial
Sign up to get notified when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.

Latest updates to the Efruxifermin in NASH Subjects Clinical Trial page
- Check5 days agoChange DetectedRemoved the related topics: 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' from the page’s MeSH/related topics section; this metadata change may affect discoverability via topic filters. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded: glossary display option, and metadata labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a revision tag 'Revision: v3.4.0'. Removed: the older lowercase labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data', along with the previous 'Revision: v3.3.4'.SummaryDifference0.2%

- Check19 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no visible changes to study details, contacts, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check26 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the page to provide broader context and links to background information.SummaryDifference0.1%

- Check33 days agoChange DetectedRemoved the topic 'Non-alcoholic fatty liver disease' and related topic 'MedlinePlus Genetics' from the page's related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded 'Non-alcoholic fatty liver disease' to the MedlinePlus Genetics related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Efruxifermin in NASH Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.